Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening

Virology

Volumn 412, Issue 2, 2011, Pages 333-340

  Mühle, Michael ^a   Bleiholder, Anne ^b   Kolb, Susanne ^c   Hübner, Janine ^c   Löchelt, Martin ^b   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LABOKLIN GMBH AND CO KG   (Germany)

Author keywords

Antibody response; ELISA; Envelope protein; Epidemiology; Epitope mapping; Feline foamy virus; Serological Screening

Indexed keywords

GAG PROTEIN; GLUTATHIONE TRANSFERASE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EXPRESSION VECTOR; FELINE FOAMY VIRUS; FEMALE; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RETROVIRUS INFECTION; SEROLOGY; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GENE PRODUCTS, GAG; MASS SCREENING; RECOMBINANT PROTEINS; RETROVIRIDAE INFECTIONS; SPUMAVIRUS; VIRAL ENVELOPE PROTEINS; VIROLOGY;

FELINE FOAMY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952620953     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.023     Document Type: Article

References (33)

1. Alke A., Schwantes A., Zemba M., Flugel R.M., Lochelt M. Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus. Virology 2000, 275:170-176.
2. Bandecchi P., Matteucci D., Baldinotti F., Guidi G., Abramo F., Tozzini F., Bendinelli M. Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy. Vet. Immunol. Immunopathol. 1992, 31:337-345.
3. Bodem J., Lochelt M., Delius H., Flugel R.M. Detection of subgenomic cDNAs and mapping of feline foamy virus mRNAs reveals complex patterns of transcription. Virology 1998, 244:417-426.
4. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89:263-273.
5. Daniels M.J., Golder M.C., Jarrett O., MacDonald D.W. Feline viruses in wildcats from Scotland. J. Wildl. Dis. 1999, 35:121-124.
6. Denner J., Norley S., Kurth R. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS 1994, 8:1063-1072.
7. Eberle J., Loussert-Ajaka I., Brust S., Zekeng L., Hauser P.H., Kaptue L., Knapp S., Damond F., Saragosti S., Simon F., Gurtler L.G. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection. J. Virol. Meth. 1997, 67:85-91.
8. Fiebig U., Stephan O., Kurth R., Denner J. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?. Virology 2003, 307:406-413.
9. Fiebig U., Hartmann M.G., Bannert N., Kurth R., Denner J. Transspecies transmission of the endogenous koala retrovirus. J. Virol. 2006, 80:5651-5654.
10. Gnann J.W., Schwimmbeck P.L., Nelson J.A., Truax A.B., Oldstone M.B. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J. Infect. Dis. 1987, 156:261-267.
11. Greenwald J.L., Burstein G.R., Pincus J., Branson B. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep. 2006, 8:125-131.
12. Guan K.L., Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 1991, 192:262-267.
13. Langhammer S., Fiebig U., Kurth R., Denner J. Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine 2005, 23:3341-3348.
14. Langhammer S., Hübner J., Kurth R., Denner J. Antibodies neutralising feline leukemia virus (FeLV) in cats immunised with the transmembrane envelope protein p15E. Immunology 2006, 117:229-237.
15. Langhammer S., Fiebig U., Hübner J., Kurth R., Denner J. Increased neutralizing antibody response after simultaneous immunization with Leucogen and the feline leukemia virus transmembrane protein. Intervirology 2010, 54:78-86.
16. Lindemann D., Goepfert P.A. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 2003, 277:111-129.
17. Linial M. Why aren't foamy viruses pathogenic?. Trends Microbiol. 2000, 8:284-289.
18. Luftenegger D., Picard-Maureau M., Stanke N., Rethwilm A., Lindemann D. Analysis and function of prototype foamy virus envelope N glycosylation. J. Virol. 2005, 79:7664-7672.
19. Luttge B.G., Freed E.O. FIV Gag: virus assembly and host-cell interactions. Vet. Immunol. Immunopathol. 2010, 134:3-13.
20. Manocha M., Chitralekha K.T., Thakar M., Shashikiran D., Paranjape R.S., Rao D.N. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies. Immunol. Lett. 2003, 85:275-278.
21. Melikyan G.B. Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology 2008, 5:111.
22. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 1993, 67:6642-6647.
23. Pietschmann T., Zentgraf H., Rethwilm A., Lindemann D. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 2000, 74:4474-4482.
24. Romen F., Pawlita M., Sehr P., Bachmann S., Schroder J., Lutz H., Lochelt M. Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats. Virology 2006, 345:502-508.
25. Sayre K.R., Dodd R.Y., Tegtmeier G., Layug L., Alexander S.S., Busch M.P. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors. Transfusion 1996, 36:45-52.
26. Shaw K.L., Lindemann D., Mulligan M.J., Goepfert P.A. Foamy virus envelope glycoprotein is sufficient for particle budding and release. J. Virol. 2003, 77:2338-2348.
27. Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 2001, 17:1757-1765.
28. Tacke S.J., Bodusch K., Berg A., Denner J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001, 8:125-135.
29. Wang G., Mulligan M.J. Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J. Gen. Virol. 1999, 80(Pt 1):245-254.
30. Winkler I.G., Lochelt M., Levesque J.P., Bodem J., Flugel R.M., Flower R.L. A rapid streptavidin-capture ELISA specific for the detection of antibodies to feline foamy virus. J. Immunol. Meth. 1997, 207:69-77.
31. Winkler I.G., Flugel R.M., Lochelt M., Flower R.L. Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology 1998, 247:144-151.
32. Winkler I.G., Lochelt M., Flower R.L. Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J. Clin. Microbiol. 1999, 37:2848-2851.
33. Zemba M., Alke A., Bodem J., Winkler I.G., Flower R.L., Pfrepper K., Delius H., Flugel R.M., Lochelt M. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology 2000, 266:150-156.